Logo image of EB

EVENTBRITE INC-CLASS A (EB) Stock Fundamental Analysis

USA - NYSE:EB - US29975E1091 - Common Stock

2.34 USD
+0.01 (+0.43%)
Last: 10/23/2025, 10:16:58 AM
Fundamental Rating

3

Taking everything into account, EB scores 3 out of 10 in our fundamental rating. EB was compared to 80 industry peers in the Entertainment industry. While EB seems to be doing ok healthwise, there are quite some concerns on its profitability. EB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

EB had negative earnings in the past year.
EB had a positive operating cash flow in the past year.
In the past 5 years EB always reported negative net income.
Of the past 5 years EB 4 years had a positive operating cash flow.
EB Yearly Net Income VS EBIT VS OCF VS FCFEB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

EB has a Return On Assets (-2.66%) which is in line with its industry peers.
EB's Return On Equity of -11.77% is in line compared to the rest of the industry. EB outperforms 45.00% of its industry peers.
Industry RankSector Rank
ROA -2.66%
ROE -11.77%
ROIC N/A
ROA(3y)-3.72%
ROA(5y)-10.96%
ROE(3y)-18.74%
ROE(5y)-41.86%
ROIC(3y)N/A
ROIC(5y)N/A
EB Yearly ROA, ROE, ROICEB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

With a decent Gross Margin value of 67.83%, EB is doing good in the industry, outperforming 78.75% of the companies in the same industry.
In the last couple of years the Gross Margin of EB has grown nicely.
EB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.76%
GM growth 5Y2.88%
EB Yearly Profit, Operating, Gross MarginsEB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

More info and screens

4

2. Health

2.1 Basic Checks

EB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EB has less shares outstanding
EB has more shares outstanding than it did 5 years ago.
The debt/assets ratio for EB has been reduced compared to a year ago.
EB Yearly Shares OutstandingEB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EB Yearly Total Debt VS Total AssetsEB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

EB has an Altman-Z score of -0.72. This is a bad value and indicates that EB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.72, EB is doing worse than 70.00% of the companies in the same industry.
The Debt to FCF ratio of EB is 5.78, which is a neutral value as it means it would take EB, 5.78 years of fcf income to pay off all of its debts.
EB has a Debt to FCF ratio of 5.78. This is in the better half of the industry: EB outperforms 62.50% of its industry peers.
A Debt/Equity ratio of 1.19 is on the high side and indicates that EB has dependencies on debt financing.
With a Debt to Equity ratio value of 1.19, EB is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF 5.78
Altman-Z -0.72
ROIC/WACCN/A
WACC4.94%
EB Yearly LT Debt VS Equity VS FCFEB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.51 indicates that EB should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.51, EB is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
A Quick Ratio of 1.51 indicates that EB should not have too much problems paying its short term obligations.
EB has a better Quick ratio (1.51) than 65.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51
EB Yearly Current Assets VS Current LiabilitesEB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

EB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.67%.
Looking at the last year, EB shows a very negative growth in Revenue. The Revenue has decreased by -11.54% in the last year.
EB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.11% yearly.
EPS 1Y (TTM)-46.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)-11.54%
Revenue growth 3Y20.22%
Revenue growth 5Y-0.11%
Sales Q2Q%-13.95%

3.2 Future

The Earnings Per Share is expected to grow by 23.29% on average over the next years. This is a very strong growth
EB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.86% yearly.
EPS Next Y19.72%
EPS Next 2Y30.85%
EPS Next 3Y34.33%
EPS Next 5Y23.29%
Revenue Next Year-9.66%
Revenue Next 2Y-0.53%
Revenue Next 3Y2.9%
Revenue Next 5Y4.86%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EB Yearly Revenue VS EstimatesEB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M
EB Yearly EPS VS EstimatesEB Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

EB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EB Price Earnings VS Forward Price EarningsEB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

EB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. EB is cheaper than 95.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.41
EV/EBITDA N/A
EB Per share dataEB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

EB's earnings are expected to grow with 34.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.85%
EPS Next 3Y34.33%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVENTBRITE INC-CLASS A

NYSE:EB (10/23/2025, 10:16:58 AM)

2.34

+0.01 (+0.43%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-06 2025-11-06
Inst Owners80.71%
Inst Owner Change-1.64%
Ins Owners6.47%
Ins Owner Change4.19%
Market Cap225.81M
Revenue(TTM)300.86M
Net Income(TTM)-20862000
Analysts45
Price Target2.91 (24.36%)
Short Float %4.6%
Short Ratio5.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)50.99%
Min EPS beat(2)24.82%
Max EPS beat(2)77.16%
EPS beat(4)3
Avg EPS beat(4)26.71%
Min EPS beat(4)-64.87%
Max EPS beat(4)77.16%
EPS beat(8)6
Avg EPS beat(8)35.3%
EPS beat(12)9
Avg EPS beat(12)39.13%
EPS beat(16)11
Avg EPS beat(16)25.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.74%
Min Revenue beat(2)-2.02%
Max Revenue beat(2)-1.45%
Revenue beat(4)0
Avg Revenue beat(4)-1.61%
Min Revenue beat(4)-2.55%
Max Revenue beat(4)-0.39%
Revenue beat(8)0
Avg Revenue beat(8)-2.44%
Revenue beat(12)1
Avg Revenue beat(12)-2.17%
Revenue beat(16)3
Avg Revenue beat(16)-1.05%
PT rev (1m)0%
PT rev (3m)-10.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)44.44%
EPS NY rev (1m)0%
EPS NY rev (3m)45.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.24%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.75
P/FCF 5.41
P/OCF 4.84
P/B 1.27
P/tB 146.15
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)0.43
FCFY18.5%
OCF(TTM)0.48
OCFY20.67%
SpS3.12
BVpS1.84
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.66%
ROE -11.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.83%
FCFM 13.88%
ROA(3y)-3.72%
ROA(5y)-10.96%
ROE(3y)-18.74%
ROE(5y)-41.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.76%
GM growth 5Y2.88%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF 5.78
Debt/EBITDA N/A
Cap/Depr 30.46%
Cap/Sales 1.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z -0.72
F-Score5
WACC4.94%
ROIC/WACCN/A
Cap/Depr(3y)45.61%
Cap/Depr(5y)35.63%
Cap/Sales(3y)2.15%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y19.72%
EPS Next 2Y30.85%
EPS Next 3Y34.33%
EPS Next 5Y23.29%
Revenue 1Y (TTM)-11.54%
Revenue growth 3Y20.22%
Revenue growth 5Y-0.11%
Sales Q2Q%-13.95%
Revenue Next Year-9.66%
Revenue Next 2Y-0.53%
Revenue Next 3Y2.9%
Revenue Next 5Y4.86%
EBIT growth 1Y2.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year162.05%
EBIT Next 3Y47.74%
EBIT Next 5Y28.21%
FCF growth 1Y266.38%
FCF growth 3Y-29.09%
FCF growth 5Y12.63%
OCF growth 1Y162.23%
OCF growth 3Y-23.38%
OCF growth 5Y4.42%